- Home
- RSSS vs LXRX Comparison
RSSS vs LXRX Comparison
Compare RSSS & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- LXRX
- Stock Information
- Founded
- RSSS 2006
- LXRX 1995
- Country
- RSSS United States
- LXRX United States
- Employees
- RSSS N/A
- LXRX N/A
- Industry
- RSSS Business Services
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- LXRX Health Care
- Exchange
- RSSS Nasdaq
- LXRX Nasdaq
- Market Cap
- RSSS 104.8M
- LXRX 124.4M
- IPO Year
- RSSS N/A
- LXRX 2000
- Fundamental
- Price
- RSSS $2.66
- LXRX $0.64
- Analyst Decision
- RSSS Strong Buy
- LXRX Buy
- Analyst Count
- RSSS 1
- LXRX 4
- Target Price
- RSSS $6.00
- LXRX $3.67
- AVG Volume (30 Days)
- RSSS 85.0K
- LXRX 32.9M
- Earning Date
- RSSS 05-08-2025
- LXRX 05-05-2025
- Dividend Yield
- RSSS N/A
- LXRX N/A
- EPS Growth
- RSSS N/A
- LXRX N/A
- EPS
- RSSS N/A
- LXRX N/A
- Revenue
- RSSS $48,207,887.00
- LXRX $31,081,000.00
- Revenue This Year
- RSSS $13.88
- LXRX N/A
- Revenue Next Year
- RSSS $7.30
- LXRX $63.36
- P/E Ratio
- RSSS N/A
- LXRX N/A
- Revenue Growth
- RSSS 18.51
- LXRX 2481.48
- 52 Week Low
- RSSS $2.32
- LXRX $0.28
- 52 Week High
- RSSS $4.24
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- RSSS 49.99
- LXRX 64.52
- Support Level
- RSSS $2.50
- LXRX $0.49
- Resistance Level
- RSSS $2.87
- LXRX $0.60
- Average True Range (ATR)
- RSSS 0.15
- LXRX 0.08
- MACD
- RSSS 0.05
- LXRX 0.02
- Stochastic Oscillator
- RSSS 61.27
- LXRX 97.54
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.